facebook twitter linkedin instagram youtube spotify
×
<
>
loading_icra
Name of Lender Facility/Instrument Amount (Rs. Crore)
Indian Bank Working Capital Facilities 1001
State Bank of India Working Capital Facilities 1001
Citibank N.A. Working Capital Facilities 1001
Axis Bank Limited Working Capital Facilities 401
IndusInd Bank Limited Working Capital Facilities 1151
ICICI Bank Limited Working Capital Facilities 801
RBL Bank Limited Working Capital Facilities 401
HDFC Bank Limited Working Capital Facilities 1201
Kotak Mahindra Bank Limited Working Capital Facilities 1101
YES Bank Limited Working Capital Facilities 101
Federal Bank Limited Working Capital Facilities 1151
Indian Bank Working Capital Facilities 302
State Bank of India Working Capital Facilities 202
YES Bank Limited Working Capital Facilities 92
Citibank N.A. Working Capital Facilities 202
Axis Bank Limited Working Capital Facilities 102
Kotak Mahindra Bank Limited Working Capital Facilities 312
Not Applicable Unallocated Limits 100

*April 03, 2025
1 Fund Based
2 Non- fund based


The details presented on this page provide an update on the names of lenders, in reference to the total credit facilities of Natco Pharma Limited rated by ICRA. To access the previous rating rationale: Click Here.


This update is being published as per the directions of the Reserve Bank of India (RBI) to the Credit Rating Agencies (CRAs) vide the communication [CO.DOR.ISG.No.S150/21-06-008/2021-2022] dated June 4, 2021.